ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Overview Fund Activity
Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

181 hedge funds and large institutions have $3.05B invested in Intercept Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 47 reducing their positions, and 21 closing their positions.

Holders
181
Holders Change
+14
Holders Change %
+8.38%
% of All Funds
5.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
37
Increased
81
Reduced
47
Closed
21
Calls
$109M
Puts
$179M
Net Calls
-$69.4M
Net Calls Change
+$62.5M

Top Buyers

1
CG
1
Carmignac Gestion
France
$315M
2
Millennium Management
2
Millennium Management
New York
$71.5M
3
CCI
3
Columbus Circle Investors
$36.4M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$74.9M
5
Franklin Resources
5
Franklin Resources
California
$77.8M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$61.6M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$62.2M
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$0
4
O
4
OrbiMed
New York
$351M
5
Norges Bank
5
Norges Bank
Norway
$29.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$753M 3,182,693 +10,745 +0.3%
O
2
OrbiMed
New York
$351M 1,485,000 -171,258 -10%
CG
3
Carmignac Gestion
France
$315M 1,330,516 +329,940 +33%
Capital World Investors
4
Capital World Investors
California
$174M 736,800 – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$172M 728,242 +78,169 +12%
Franklin Resources
6
Franklin Resources
California
$77.8M 328,757 +138,657 +73%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$74.9M 316,512 +150,317 +90%
BIT
8
BlackRock Institutional Trust
California
$72.9M 307,894 +8,530 +3%
Millennium Management
9
Millennium Management
New York
$71.5M 302,012 +293,732 +3,547%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$62.2M 262,586 -359,444 -58%
Jennison Associates
11
Jennison Associates
New York
$61.6M 260,195 -1,166,923 -82%
State Street
12
State Street
Massachusetts
$46.7M 197,329 +21,412 +12%
CWAM
13
Columbia Wanger Asset Management
Illinois
$43.4M 183,300 – –
Lord, Abbett & Co
14
Lord, Abbett & Co
New Jersey
$42.7M 180,491 -24,144 -12%
CCI
15
Columbus Circle Investors
$36.4M 153,808 +153,808 New
GGHC
16
Gilder Gagnon Howe & Co
New York
$36.1M 152,444 +7,147 +5%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$30.4M 128,368 +92,038 +253%
Morgan Stanley
18
Morgan Stanley
New York
$29.5M 124,698 +39,854 +47%
Norges Bank
19
Norges Bank
Norway
$29.1M 123,083 -123,083 -50%
DM
20
Deerfield Management
New York
$23.4M 98,693 +98,693 New
BFA
21
BlackRock Fund Advisors
California
$23M 97,316 +15,346 +19%
UBS AM
22
UBS AM
Illinois
$22M 93,125 +3,925 +4%
Ameriprise
23
Ameriprise
Minnesota
$21.4M 90,559 +29,431 +48%
Bank of America
24
Bank of America
North Carolina
$19.9M 83,970 -2,849 -3%
Invesco
25
Invesco
Georgia
$19.4M 82,087 +7,038 +9%
1
2 3 4 5